
Latest News in Parkinson Disease: Treating Advanced Disease, Updated AAN Guidelines on Dementia Care, and More
An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.
An overview of the latest news in
Common Strategies to Manage Advanced PD
In a Peer Exchange series by
Notably, educating patients on the significance of
Moreover, as those with advanced disease are more likely to experience OFF periods, adjusting or adding to the currently prescribed medication, device-aided therapy, or a combination of both may be warranted to maintain an optimal dopamine level.
AAN Issues Ethical Guidance on Dementia Diagnosis, Care
This week, the American Academy of Neurology (AAN) issued an updated ethical guidance for neurologists and neuroscience professionals who manage the care of patients with Alzheimer disease and other
Published in
The new ethical guidance serves as an update to the AAN’s 1996 position statement on ethical considerations for dementia care. As the guidance was developed before the FDA approval of
Advances in Neuromodulation for Movement Disorders
As reported by
Focusing primarily on
In their findings, patients of the intervention group exhibited a mean difference of 3.03 ± 4.52 hours (P < .001) of increased ON time without dyskinesia, with a 46% improvement observed in Unified Parkinson Disease Rating Scale-3 scores after 3 years, compared with the reference group.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.